CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 86 filers reported holding CYTEK BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,498 | -35.4% | 8,967 | 0.0% | 0.00% | – |
| Q2 2023 | $76,578 | -7.1% | 8,967 | 0.0% | 0.00% | – |
| Q1 2023 | $82,407 | -10.0% | 8,967 | 0.0% | 0.00% | – |
| Q4 2022 | $91,553 | -30.6% | 8,967 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $132,000 | +37.5% | 8,967 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $96,000 | – | 8,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |